Latest Tenders From Germany

Conclusion of Non-Exclusive Discount Agreements According to § 130A Para. 8 Sgb V for the in Ii.2.4. Mentioned Active Ingredients with the Possibility of Conclusion Within the Framework of the So-Called Open-House Procedure.

Conclusion of Non-Exclusive Discount Agreements According to § 130A Para. 8 Sgb V for the in Ii.2.4. Mentioned Active Ingredients with the Possibility of Conclusion Within the Framework of the So-Called Open-House Procedure.

Open House Original Discount Contracts 2023-19 - Glycopyrronium Bromide/Formoterol (Combination of Active Ingredients)

Open House Contracts 2023

Conclusion of Non-Exclusive Drug Discount Agreements According to § 130A Para. 8 Sgb V by Means of a So-Called Open House Model for the Active Substance Fusidic Acid/Betamethasone (Atc Code According to Who: D07cc01)

Completion of Non-exclusive Drug Discounts According to Section 130a (8) Sgb V by Means of a So-called Open-house Model to the Active Ingredient Fusidic Acid/betamethasone (atc Code According to Who: D07cc01)

Oh-Biologika-2023-14 - Insulin Isophane/Insulin, Normal (Human) (Combination of Active Ingredients) (Dosage Form: Cylinder Ampoules)

Oh-Biologika-2023-13 - Insulin Isophane (Human) (Dosage Form: Cylinder Ampoules)

Oh-Biologika-2023-12 - Insulin, Normal (Human) (Dosage Form: Cylinder Ampoules)

Saso - Security Assessment and System Optimisation